Patient received second dose of Moderna 2024-2025 vaccine outside of ACIP protocol (not having immunocompromised state). Patient did not report any S/Es outside of soreness at the injection site.
Patient received second dose of Moderna 2024-2025 vaccine outside of ACIP protocol (not having immunocompromised state). Patient did not report any S/Es outside of soreness at the injection site.